基本情報
- 所属
- 自治医科大学 附属病院臨床研究センター臨床研究・治験推進部 准教授
- 学位
- 医学博士(自治医科大学)
- 通称等の別名
- 和田 妙子
- 研究者番号
- 30382956
- ORCID ID
https://orcid.org/0000-0001-6825-8559
- J-GLOBAL ID
- 201401083241584853
- researchmap会員ID
- B000237836
- 外部リンク
研究キーワード
3経歴
6-
2024年2月 - 現在
-
2023年4月 - 現在
-
2020年4月 - 現在
-
2019年10月 - 2024年1月
-
2018年4月 - 2020年3月
委員歴
2-
2024年4月 - 現在
-
2023年4月 - 現在
論文
26-
Scientific reports 11(1) 20658-20658 2021年10月19日NKIRAS1 and NKIRAS2 (also called as κB-Ras) were identified as members of the atypical RAS family that suppress the transcription factor NF-κB. However, their function in carcinogenesis is still controversial. To clarify how NKIRAS acts on cellular transformation, we generated transgenic mice in which NKIRAS2 was forcibly expressed using a cytokeratin 15 (K15) promoter, which is mainly activated in follicle bulge cells. The ectopic expression of NKIRAS2 was mainly detected in follicle bulges of transgenic mice with NKIRAS2 but not in wild type mice. K15 promoter-driven expression of NKIRAS2 failed to affect the development of epidermis, which was evaluated using the expression of K10, K14, K15 and filaggrin. However, K15 promoter-driven expression of NKIRAS2 effectively suppressed the development of skin tumors induced by treatment with 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA). This observation suggested that NKIRAS seemed to function as a tumor suppressor in follicle bulges. However, in the case of oncogenic HRAS-driven cellular transformation of murine fibroblasts, knockdown of NKIRAS2 expression drastically suppressed HRAS-mutant-provoked cellular transformation, suggesting that NKIRAS2 was required for the cellular transformation of murine fibroblasts. Furthermore, moderate enforced expression of NKIRAS2 augmented oncogenic HRAS-provoked cellular transformation, whereas an excess NKIRAS2 expression converted its functional role into a tumor suppressive phenotype, suggesting that NKIRAS seemed to exhibit a biphasic bell-shaped enhancing effect on HRAS-mutant-provoked oncogenic activity. Taken together, the functional role of NKIRAS in carcinogenesis is most likely determined by not only cellular context but also its expression level.
-
Scientific reports 10(1) 8521-8521 2020年5月22日 査読有りLSD1/KDM1A is a widely conserved lysine-specific demethylase that removes methyl groups from methylated proteins, mainly histone H3. We previously isolated the zebrafish LSD1 gene and demonstrated that it is required for primitive hematopoiesis. Recently, a neuron-specific splicing variant of LSD1 was found in mammals and its specific functions and substrate specificities were reported. To our surprise, zebrafish LSD1 cDNA, which we previously analyzed, was corresponded to the neuron-specific variant in mammals. In this study, we investigated the structures and expression of LSD1 splicing variants in zebrafish and found all 4 types of LSD1 isoforms: LSD1, LSD1+2al, LSD1+8al and LSD1+2al8al. Interestingly, LSD1+8al/LSD1+2al8al, which correspond to mammalian neuron-specific variants, expressed ubiquitously in zebrafish. We also performed phenotypic rescue experiments of a zebrafish LSD1 mutant (kdm1ait627) using human and zebrafish LSD1 variants to identify which variant is involved in primitive hematopoiesis. Unexpectedly, the overexpression of all types of human and zebrafish variants was able to rescue the hematopoietic phenotypes in LSD1 mutants. Furthermore, enzymatic-deficient LSD1K661A (human) and K638A (zebrafish) were also able to rescue the mutant phenotypes. These results suggest that the LSD1 functions in zebrafish primitive hematopoiesis are free from any splicing-dependent regulation or demethylation reaction.
-
Leukemia research 82 29-32 2019年7月 査読有り
-
The Journal of clinical investigation 125(12) 4375-90 2015年10月26日 査読有り
-
Blood 125(24) 3731-46 2015年6月11日 査読有り
-
The Journal of biological chemistry 288(35) 25593-602 2013年8月30日 査読有り
-
PloS one 8(4) e60649 2013年 査読有り
-
Journal of cellular physiology 227(3) 1138-47 2012年3月 査読有り
-
EMBO reports 13(2) 142-9 2012年2月1日 査読有り
-
LEUKEMIA 24(10) 1760-1768 2010年10月 査読有り
-
Blood 116(3) 406-17 2010年7月22日 査読有り
-
LEUKEMIA 24(5) 1087-1090 2010年5月 査読有り
-
The Journal of biological chemistry 284(44) 30673-83 2009年10月30日 査読有り
-
Cell metabolism 10(3) 219-28 2009年9月 査読有り
-
ONCOGENE 28(2) 231-242 2009年1月 査読有り
-
ONCOGENE 27(22) 3102-3110 2008年5月 査読有り
-
Stem cells (Dayton, Ohio) 25(10) 2439-47 2007年10月 査読有り
-
Molecular cancer research : MCR 3(6) 325-34 2005年6月 査読有り
-
European journal of biochemistry 269(11) 2708-15 2002年6月 査読有りIn this study, we isolated a 25-kDa novel snake venom protein, designated ablomin, from the venom of the Japanese Mamushi snake (Agkistrodon blomhoffi). The amino-acid sequence of this protein was determined by peptide sequencing and cDNA cloning. The deduced sequence showed high similarity to helothermine from the Mexican beaded lizard (Heloderma horridum horridum), which blocks voltage-gated calcium and potassium channels, and ryanodine receptors. Ablomin blocked contraction of rat tail arterial smooth muscle elicited by high K+-induced depolarization in the 0.1-1 microm range, but did not block caffeine-stimulated contraction. Furthermore, we isolated three other proteins from snake venoms that are homologous to ablomin and cloned the corresponding cDNAs. Two of these homologous proteins, triflin and latisemin, also inhibited high K+-induced contraction of the artery. These results indicate that several snake venoms contain novel proteins with neurotoxin-like activity.
-
European Journal of Biochemistry 269, 2708-2715. 2002年 査読有り
MISC
28-
EXPERIMENTAL HEMATOLOGY 43(9) S63-S63 2015年9月
-
EXPERIMENTAL HEMATOLOGY 43(9) S64-S64 2015年9月
-
自治医科大学紀要 = Jichi Medical University Journal 35 131-132 2013年3月平成23年度自治医科大学医学部研究奨励金研究成果報告
講演・口頭発表等
6所属学協会
5共同研究・競争的資金等の研究課題
4-
文部科学省 科学研究費補助金(基盤研究(C)) 2015年 - 2017年
-
文部科学省 科学研究費補助金(若手研究(B)) 2013年 - 2014年
-
文部科学省 科学研究費補助金(若手研究(B)) 2011年 - 2012年
-
日本学術振興会 科学研究費助成事業 2006年 - 2007年